These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Endotoxemia rocks sphingolipid metabolism at the blood-brain barrier: An Editorial Highlight for 'Alteration of sphingolipid metabolism as a putative mechanism underlying LPS-induced BBB disruption' on page 172. Camerer E J Neurochem; 2018 Jan; 144(2):115-117. PubMed ID: 29285771 [TBL] [Abstract][Full Text] [Related]
4. Elevation of serum sphingosine-1-phosphate attenuates impaired cardiac function in experimental sepsis. Coldewey SM; Benetti E; Collino M; Pfeilschifter J; Sponholz C; Bauer M; Huwiler A; Thiemermann C Sci Rep; 2016 Jun; 6():27594. PubMed ID: 27277195 [TBL] [Abstract][Full Text] [Related]
5. Poldip2 mediates blood-brain barrier disruption in a model of sepsis-associated encephalopathy. Kikuchi DS; Campos ACP; Qu H; Forrester SJ; Pagano RL; Lassègue B; Sadikot RT; Griendling KK; Hernandes MS J Neuroinflammation; 2019 Nov; 16(1):241. PubMed ID: 31779628 [TBL] [Abstract][Full Text] [Related]
6. In vivo intrabursal administration of bioactive lipid sphingosine-1-phosphate enhances vascular integrity in a rat model of ovarian hyperstimulation syndrome. Di Pietro M; Pascuali N; Scotti L; Irusta G; Bas D; May M; Tesone M; Abramovich D; Parborell F Mol Hum Reprod; 2017 Jun; 23(6):417-427. PubMed ID: 28379469 [TBL] [Abstract][Full Text] [Related]
7. Kaempferol mitigates sepsis-induced acute lung injury by modulating the SphK1/S1P/S1PR1/MLC2 signaling pathway to restore the integrity of the pulmonary endothelial cell barrier. Gao M; Zhu X; Gao X; Yang H; Li H; Du Y; Gao J; Chen Z; Dong H; Wang B; Zhang L Chem Biol Interact; 2024 Aug; 398():111085. PubMed ID: 38823539 [TBL] [Abstract][Full Text] [Related]
8. Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli? Spampinato SF; Obermeier B; Cotleur A; Love A; Takeshita Y; Sano Y; Kanda T; Ransohoff RM PLoS One; 2015; 10(7):e0133392. PubMed ID: 26197437 [TBL] [Abstract][Full Text] [Related]
9. Activation of sphingosine kinase-1 reverses the increase in lung vascular permeability through sphingosine-1-phosphate receptor signaling in endothelial cells. Tauseef M; Kini V; Knezevic N; Brannan M; Ramchandaran R; Fyrst H; Saba J; Vogel SM; Malik AB; Mehta D Circ Res; 2008 Nov; 103(10):1164-72. PubMed ID: 18849324 [TBL] [Abstract][Full Text] [Related]
11. Mrp1 is essential for sphingolipid signaling to p-glycoprotein in mouse blood-brain and blood-spinal cord barriers. Cartwright TA; Campos CR; Cannon RE; Miller DS J Cereb Blood Flow Metab; 2013 Mar; 33(3):381-8. PubMed ID: 23168528 [TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit. Banks WA; Gray AM; Erickson MA; Salameh TS; Damodarasamy M; Sheibani N; Meabon JS; Wing EE; Morofuji Y; Cook DG; Reed MJ J Neuroinflammation; 2015 Nov; 12():223. PubMed ID: 26608623 [TBL] [Abstract][Full Text] [Related]
13. Sphingosine 1-Phosphate Signaling Is Involved in Impaired Blood-Brain Barrier Function in Ischemia-Reperfusion Injury. Nakagawa S; Aruga J Mol Neurobiol; 2020 Mar; 57(3):1594-1606. PubMed ID: 31802363 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and deposition of basement membrane proteins by primary brain capillary endothelial cells in a murine model of the blood-brain barrier. Thomsen MS; Birkelund S; Burkhart A; Stensballe A; Moos T J Neurochem; 2017 Mar; 140(5):741-754. PubMed ID: 27456748 [TBL] [Abstract][Full Text] [Related]
15. Sphingosine-1-Phosphate Receptor-1 Agonist Sew2871 Causes Severe Cardiac Side Effects and Does Not Improve Microvascular Barrier Breakdown in Sepsis. Flemming S; Burkard N; Meir M; Schick MA; Germer CT; Schlegel N Shock; 2018 Jan; 49(1):71-81. PubMed ID: 28538086 [TBL] [Abstract][Full Text] [Related]
16. Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain. Cannon RE; Peart JC; Hawkins BT; Campos CR; Miller DS Proc Natl Acad Sci U S A; 2012 Sep; 109(39):15930-5. PubMed ID: 22949658 [TBL] [Abstract][Full Text] [Related]
17. Activation of AMPK improves lipopolysaccharide-induced dysfunction of the blood-brain barrier in mice. Yu HY; Cai YB; Liu Z Brain Inj; 2015; 29(6):777-84. PubMed ID: 25794165 [TBL] [Abstract][Full Text] [Related]
18. Fingolimod (FTY720-P) Does Not Stabilize the Blood-Brain Barrier under Inflammatory Conditions in an in Vitro Model. Schuhmann MK; Bittner S; Meuth SG; Kleinschnitz C; Fluri F Int J Mol Sci; 2015 Dec; 16(12):29454-66. PubMed ID: 26690412 [TBL] [Abstract][Full Text] [Related]
19. Baicalin reduces the permeability of the blood-brain barrier during hypoxia in vitro by increasing the expression of tight junction proteins in brain microvascular endothelial cells. Zhu H; Wang Z; Xing Y; Gao Y; Ma T; Lou L; Lou J; Gao Y; Wang S; Wang Y J Ethnopharmacol; 2012 Jun; 141(2):714-20. PubMed ID: 21920425 [TBL] [Abstract][Full Text] [Related]
20. Modeling and rescue of defective blood-brain barrier function of induced brain microvascular endothelial cells from childhood cerebral adrenoleukodystrophy patients. Lee CAA; Seo HS; Armien AG; Bates FS; Tolar J; Azarin SM Fluids Barriers CNS; 2018 Apr; 15(1):9. PubMed ID: 29615068 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]